Funded Artificial Intelligence Startups in Austin
Among the 50 AI-focused funding entries in Austin shown here, the only disclosed round above the $100M range is Core Scientific’s $3.3B (2026-04-22).
Among the 50 AI-focused funding entries in Austin shown here, the only disclosed round above the $100M range is Core Scientific’s $3.3B (2026-04-22). Everything else clusters far below that level, with the next-highest disclosed amounts including Apptronik’s $520M (2026-02-11) and Saronic’s $600M (2025-02-18), creating a clear size outlier at the top.
Timing is also concentrated: the most recent activity spans from 2026-06-17 (Circuit, $30M) down to 2026-04-16 (Tailsight, undisclosed), and within that window multiple disclosed rounds sit in the millions (e.g., ContextQA at $6M on 2026-04-26; Insight Health at $11M on 2026-04-03). Stage data skews toward early rounds or classifications that are not specified: “undisclosed” appears 7 times, and “Series Unknown” appears 15 times, while disclosed amounts at Seed and Pre-Seed show up repeatedly alongside several single large-ticket events (e.g., Halcyon’s $100M on 2024-11-25; SchooLinks’s $80M on 2024-10-21).
Most recent rounds
50 of 8535 more funded startups
This page shows the 50 most recent rounds (back to Oct 2023). The full 85-company history for this listing is available on a paid plan.
Unlock all 85 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
Which disclosed round is the size outlier in this Austin AI list, and how does it compare to the rest?
Core Scientific’s $3.3B on 2026-04-22 is the standout outlier; it is the only disclosed amount above $100M. The next-largest disclosed rounds are still far smaller, including Saronic’s $600M (2025-02-18) and Apptronik’s $520M (2026-02-11).
How much of the recent momentum falls into a tight date window near the top of the table?
The latest disclosed entry is Circuit’s $30M on 2026-06-17, with several additional rounds in mid-to-late June and early June (e.g., 9 Mothers on 2026-06-16 for $500K; Intellectible on 2026-06-04 for $3M). A dense cluster continues into April 2026, including ContextQA’s $6M (2026-04-26) and Insight Health’s $11M (2026-04-03).
What does the data suggest about stage disclosure and classification gaps (Seed vs. unspecified)?
Unspecified or missing stage information is common: “Series Unknown” appears 15 times and “undisclosed” appears 7 times. Seed/Pre-Seed are also frequent among disclosed amounts (e.g., Intellectible $3M on 2026-06-04 as Seed; MakerSquare $100K on 2026-05-08 as Pre-Seed), so the list mixes early-stage signals with many categories that are harder to benchmark.
Are there multiple high-dollar late-stage rounds that change the risk profile compared with smaller tickets?
Yes, the upper tail includes large disclosed rounds beyond a single event: Halcyon’s $100M on 2024-11-25 (Series C) and SchooLinks’s $80M on 2024-10-21 (Series B) sit well above the many sub-$20M disclosed entries. Separately, Saronic’s $600M on 2025-02-18 (Series C) indicates that a few entries behave like scale-up/transition financing rather than early experiments.
Do you see any clear low-end disclosed amounts that could indicate very small initial checks in the dataset?
At the low end, Gleantap’s $20K on 2023-12-01 (Series Unknown) is the smallest disclosed amount in the rows shown. That contrasts with many Seed/Pre-Seed disclosed checks in the hundreds of thousands to low single-digit millions (e.g., Arintra $200K on 2025-07-25; Entytle $390K on 2024-03-08).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.